Wegovy

Novo Nordisk shares rise after Wegovy obesity pill launch

Read more

Novo Nordisk faces ‘must-win’ battle over U.S. Wegovy, Ozempic in 2026

Read more

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

Read more

Novo Nordisk cuts cash prices for Wegovy, Ozempic

Read more

Wegovy, Ozempic maker Novo Nordisk Q3 earnings

Read more

Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug

Read more

Novo Nordisk opens Wegovy to telehealth in push for new patients

Read more